Stay updated with breaking news from Catriona yale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) insider Catriona Yale sold 2,825 shares of the stock in a transaction on Tuesday, June 11th. The shares were sold at an average price of $22.64, for a total value of $63,958.00. Following the completion of the sale, the insider now owns 74,867 shares of the company’s […] ....
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) insider Catriona Yale sold 2,825 shares of the company’s stock in a transaction dated Tuesday, June 11th. The shares were sold at an average price of $22.64, for a total transaction of $63,958.00. Following the transaction, the insider now owns 74,867 shares in the company, valued at […] ....
Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the eight brokerages that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12 month price […] ....
Canaccord Genuity Group Trims Akero Therapeutics (NASDAQ:AKRO) Target Price to $56.00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reissued their buy rating on shares of Akero Therapeutics (NASDAQ:AKRO – Free Report) in a research note released on Monday morning, Benzinga reports. They currently have a $50.00 price objective on the stock. HC Wainwright also issued estimates for Akero Therapeutics’ Q2 2024 earnings at ($0.82) EPS, Q3 2024 earnings at ($0.87) EPS, […] ....